3 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 600,000 600,000 18,697 18,697 18,697 xbrli:pure xbrli:shares iso4217:GBP 08272053 2024-04-01 2025-03-31 08272053 2025-03-31 08272053 2024-03-31 08272053 2023-04-01 2024-03-31 08272053 2024-03-31 08272053 2023-03-31 08272053 bus:Director3 2024-04-01 2025-03-31 08272053 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 08272053 core:WithinOneYear 2025-03-31 08272053 core:WithinOneYear 2024-03-31 08272053 core:ShareCapital 2025-03-31 08272053 core:ShareCapital 2024-03-31 08272053 core:SharePremium 2025-03-31 08272053 core:SharePremium 2024-03-31 08272053 core:RetainedEarningsAccumulatedLosses 2025-03-31 08272053 core:RetainedEarningsAccumulatedLosses 2024-03-31 08272053 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 08272053 core:Non-currentFinancialInstruments 2025-03-31 08272053 core:Non-currentFinancialInstruments 2024-03-31 08272053 bus:SmallEntities 2024-04-01 2025-03-31 08272053 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08272053 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 08272053 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08272053 bus:FullAccounts 2024-04-01 2025-03-31 08272053 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-01 2025-03-31
COMPANY REGISTRATION NUMBER: 08272053
Cambridge Healthcare Supplies 2012 Limited
Unaudited financial statements
31 March 2025
Cambridge Healthcare Supplies 2012 Limited
Statement of financial position
31 March 2025
2025
2024
Note
£
£
£
£
Fixed assets
Investments
6
18,697
18,697
Current assets
Debtors
7
1,639,008
1,640,628
Creditors: Amounts falling due within one year
8
( 662)
( 662)
-----------
-----------
Net current assets
1,638,346
1,639,966
-----------
-----------
Total assets less current liabilities
1,657,043
1,658,663
Accruals and deferred income
( 1,620)
-----------
-----------
Net assets
1,657,043
1,657,043
-----------
-----------
Capital and reserves
Called up share capital
10,000
10,000
Share premium account
1,285,264
1,285,264
Profit and loss account
361,779
361,779
-----------
-----------
Shareholders funds
1,657,043
1,657,043
-----------
-----------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 11 December 2025 , and are signed on behalf of the board by:
Miss P Ondhia
Director
Company registration number: 08272053
Cambridge Healthcare Supplies 2012 Limited
Notes to the financial statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 1, Wymondham Business Park, Chestnut Drive, Wymondham, NR18 9SB.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably .
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Product Licences
-
Fully amortised
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
4. Employee numbers
The average number of employees during the year was 3 (2024: 3 ).
5. Intangible assets
Product Licences
£
Cost
At 1 April 2024 and 31 March 2025
600,000
---------
Amortisation
At 1 April 2024 and 31 March 2025
600,000
---------
Carrying amount
At 31 March 2025
---------
At 31 March 2024
---------
6. Investments
Shares in group undertakings
£
Cost
At 1 April 2024 and 31 March 2025
18,697
-------
Impairment
At 1 April 2024 and 31 March 2025
-------
Carrying amount
At 31 March 2025
18,697
-------
At 31 March 2024
18,697
-------
7. Debtors
2025
2024
£
£
Amounts owed by group undertakings
1,639,008
1,640,628
-----------
-----------
8. Creditors: Amounts falling due within one year
2025
2024
£
£
Amounts owed to group undertakings
662
662
----
----